There is no hope for this POS, unless the shell is sold. I remember reading no reverse splits for the first 17 years Now three reverse splits in four years and they will do it again and again. MONEY GONE!!! Only went up on Covid and cancer hype. Company has no operations.
Ha! There is always hope I guess. Other posters have been correct in that this pattern repeats itself. A RS and NSPX does nothing to (or doesn't want to) or can't defend the PPS and there is a low volume slide back to pre RS prices. Frustrating for sure. It has happened before and may happen again. For years Genspera/Inspyr proponents blamed the lack of development of mipsagargin for the lack of a supply chain for thapsigargin. The hope is now with the pending patent for Phyton some one will pick up mipsagargin and take it into PH III.